Boerboom Heads CSR Division

Dr. Lawrence Boerboom is the new director of the Division of Physiological and Pathological Sciences at the Center for Scientific Review. He has been chief of CSR’s cardiovascular and respiratory sciences integrated review group since 2009.

“We are pleased that Dr. Boerboom has agreed to step into this important position,” said CSR director Dr. Richard Nakamura. “He has excelled as a leader in academia, business and CSR, and he will bring a wealth of management and scientific expertise to the job…Throughout his career, Dr. Boerboom has successfully built bridges between basic and clinical researchers and cultivated a deep appreciation for multidisciplinary research.”   

The Division of Physiological and Pathological Sciences coordinates reviews of NIH grant applications in four integrated review groups—digestive, kidney and urological systems; endocrinology, metabolism, nutrition and reproductive sciences; infectious diseases and microbiology; and immunology—that include 44 standing review panels managed by an equal number of scientific review officers.

Boerboom came to CSR in 2004 as an SRO for a study section that reviews cardiac- and vascular-related small business grant applications.  

Prior to joining CSR, he was director of research at LifeCell Corp. in Branchburg, N.J., where he led a team developing tissue-engineered medical devices. He earlier had a 20-year career on the faculty of the Medical College of Wisconsin, holding a primary appointment in cardiothoracic surgery and a secondary appointment in physiology. 

Boerboom also served as director of cardiovascular surgical research. His research focused on factors influencing myocardial blood flow, cardiac function and vascular bypass graft atherosclerosis. He earned his Ph.D. in physiology from the University of North Dakota.